{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:43:39Z","timestamp":1762177419586,"version":"3.37.3"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00702-021-02345-9","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T17:02:26Z","timestamp":1619715746000},"page":"687-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases"],"prefix":"10.1007","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"2345_CR1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH (2017) Hippocampal alpha-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci 37:1675\u20131684","journal-title":"J Neurosci"},{"key":"2345_CR2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kov\u00c3\u00a1cs GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H, (2008) Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe Consortium. Brain Pathol 18:484\u2013496","journal-title":"Brain Pathol"},{"key":"2345_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I, Boluda S, Bugiani O, Duyckaerts C, Gelpi E, Gentleman S, Giaccone G, Graeber M, Hortobagyi T, H\u00f6ftberger R, Ince P, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kov\u00e1cs GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Pikkarainen M, Revesz T, Rozemuller A, Seilhean D, Schulz-Schaeffer W, Streichenberger N, Wharton SB, Kretzschmar H (2009) Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:309\u2013320","journal-title":"Acta Neuropathol"},{"key":"2345_CR4","doi-asserted-by":"crossref","first-page":"e12145","DOI":"10.1002\/trc2.12145","volume":"7","author":"V Alakbarzade","year":"2021","unstructured":"Alakbarzade V, French JM, Howlett DR, Attems J, Francis PT, Stratton S, Clark CN, Pereira AC, Hainsworth AH (2021) Cerebral amyloid angiopathy distribution in older people: a cautionary note. Alzheimers Dement (N Y) 7:e12145","journal-title":"Alzheimers Dement (N Y)"},{"key":"2345_CR5","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-5)","author":"American, Association AP","year":"2013","unstructured":"American, Association AP (2013) Diagnostic and statistical manual of mental disorders (DSM-5), 5th edn. American Psychiatric Association, Arlington","edition":"5"},{"key":"2345_CR6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.22112","volume":"69","author":"Z Arvanitakis","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA (2011) Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 69:320\u2013327","journal-title":"Ann Neurol"},{"key":"2345_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","volume":"107","author":"J Attems","year":"2004","unstructured":"Attems J, Jellinger KA (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology\u2014a pilot study. Acta Neuropathol 107:83\u201390","journal-title":"Acta Neuropathol"},{"key":"2345_CR8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J, Jellinger KA, Lintner F (2005) Alzheimer\u2019s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol (Berl) 110:222\u2013231","journal-title":"Acta Neuropathol (Berl)"},{"key":"2345_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2990.2010.01137.x","volume":"37","author":"J Attems","year":"2011","unstructured":"Attems J, Jellinger K, Thal DR, Van Nostrand W (2011) Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37:75\u201393","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2345_CR10","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","volume":"67","author":"C Ballard","year":"2006","unstructured":"Ballard C, Ziabreva I, Perry R, Larsen JP, O\u2019Brien J, McKeith I, Perry E, Aarsland D (2006) Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67:1931\u20131934","journal-title":"Neurology"},{"key":"2345_CR11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s004010050726","volume":"94","author":"C Bancher","year":"1997","unstructured":"Bancher C, Egensperger R, Kosel S, Jellinger K, Graeber MB (1997) Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathol (Berl) 94:403\u2013409","journal-title":"Acta Neuropathol (Berl)"},{"key":"2345_CR12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1556\/650.2020.31715","volume":"161","author":"V Bencs","year":"2020","unstructured":"Bencs V, Bencze J, M\u00f3dis VL, Simon V, K\u00e1lm\u00e1n J, Hortob\u00e1gyi T (2020) Pathological and clinical comparison of Parkinson\u2019s disease dementia and dementia with Lewy bodies] [Article in Hu]. Orv Hetil 161:727\u2013737","journal-title":"Orv Hetil"},{"key":"2345_CR13","first-page":"255","volume":"46","author":"E Bertrand","year":"2008","unstructured":"Bertrand E, Lewandowska E, Stepien T, Szpak GM, Pasennik E, Modzelewska J (2008) Amyloid angiopathy in idiopathic Parkinson\u2019s disease. Immunohistochemical and ultrastructural study. Folia Neuropathol 46:255\u2013270","journal-title":"Folia Neuropathol"},{"key":"2345_CR14","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","volume":"85","author":"PA Boyle","year":"2015","unstructured":"Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, Schneider JA (2015) Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 85:1930\u20131936","journal-title":"Neurology"},{"key":"2345_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239\u2013259","journal-title":"Acta Neuropathol (Berl)"},{"key":"2345_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2345_CR17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.10455","volume":"18","author":"DJ Burn","year":"2003","unstructured":"Burn DJ, Rowan EN, Minett T, Sanders J, Myint P, Richardson J, Thomas A, Newby J, Reid J, O\u2019Brien JT, McKeith IG (2003) Extrapyramidal features in Parkinson\u2019s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord 18:884\u2013889","journal-title":"Mov Disord"},{"key":"2345_CR18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/brain\/awh088","volume":"127","author":"EJ Burton","year":"2004","unstructured":"Burton EJ, McKeith IG, Burn DJ, Williams ED, O\u2019Brien JT (2004) Cerebral atrophy in Parkinson\u2019s disease with and without dementia: a comparison with Alzheimer\u2019s disease, dementia with Lewy bodies and controls. Brain 127:791\u2013800","journal-title":"Brain"},{"key":"2345_CR19","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.10444","volume":"18","author":"R Camicioli","year":"2003","unstructured":"Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson\u2019s disease is associated with hippocampal atrophy. Mov Disord 18:784\u2013790","journal-title":"Mov Disord"},{"key":"2345_CR20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-019-0473-4","volume":"11","author":"SP Caminiti","year":"2019","unstructured":"Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D (2019) Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther 11:20","journal-title":"Alzheimers Res Ther"},{"key":"2345_CR21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jnnp-2011-301308","volume":"83","author":"A Charidimou","year":"2012","unstructured":"Charidimou A, Gang Q, Werring DJ (2012) Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 83:124\u2013137","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2345_CR22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fneur.2019.00369","volume":"10","author":"D Chen","year":"2019","unstructured":"Chen D, Jiang J, Lu J, Wu P, Zhang H, Zuo C, Shi K (2019) Brain network and abnormal hemispheric asymmetry analyses to explore the marginal differences in glucose metabolic distributions among Alzheimer\u2019s disease, Parkinson\u2019s disease dementia, and Lewy body dementia. Front Neurol 10:369","journal-title":"Front Neurol"},{"key":"2345_CR23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J, Makarious MB, Diez-Fairen M, Portley MK, Shah Z, Abramzon Y, Hernandez DG, Blauwendraat C, Stone DJ, Eicher J, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, St George-Hyslop P, Londos E, Morgan K, Lashley T, Warner TT, Jaunmuktane Z, Galasko D, Santana I, Tienari PJ, Myllykangas L, Oinas M, Cairns NJ, Morris JC, Halliday GM, Van Deerlin VM, Trojanowski JQ, Grassano M, Calvo A, Mora G, Canosa A, Floris G, Bohannan RC, Brett F, Gan-Or Z, Geiger JT, Moore A, May P, Kr\u00fcger R, Goldstein DS, Lopez G, Tayebi N, Sidransky E, Norcliffe-Kaufmann L, Palma JA, Kaufmann H, Shakkottai VG, Perkins M, Newell KL, Gasser T, Schulte C, Landi F, Salvi E, Cusi D, Masliah E, Kim RC, Caraway CA, Monuki ES, Brunetti M, Dawson TM, Rosenthal LS, Albert MS, Pletnikova O, Troncoso JC, Flanagan ME, Mao Q, Bigio EH, Rodr\u00edguez-Rodr\u00edguez E, Infante J, Lage C, Gonz\u00e1lez-Aramburu I, Sanchez-Juan P, Ghetti B, Keith J, Black SE, Masellis M, Rogaeva E, Duyckaerts C, Brice A, Lesage S, Xiromerisiou G, Barrett MJ, Tilley BS, Gentleman S, Logroscino G, Serrano GE, Beach TG, McKeith IG, Thomas AJ, Attems J, Morris CM, Palmer L, Love S, Troakes C, Al-Sarraj S, Hodges AK, Aarsland D, Klein G, Kaiser SM, Woltjer R, Pastor P, Bekris LM, Leverenz JB, Besser LM, Kuzma A, Renton AE, Goate A, Bennett DA, Scherzer CR, Morris HR, Ferrari R, Albani D, Pickering-Brown S, Faber K, Kukull WA, Morenas-Rodriguez E, Lle\u00f3 A, Fortea J, Alcolea D, Clarimon J, Nalls MA, Ferrucci L, Resnick SM, Tanaka T, Foroud TM, Graff-Radford NR, Wszolek ZK, Ferman T, Boeve BF, Hardy JA, Topol EJ, Torkamani A, Singleton AB, Ryten M, Dickson DW, Chi\u00f2 A, Ross OA, Gibbs JR, Dalgard CL, Traynor BJ, Scholz SW (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53:294\u2013303","journal-title":"Nat Genet"},{"key":"2345_CR24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.parkreldis.2020.09.030","volume":"80","author":"KS Chin","year":"2020","unstructured":"Chin KS, Yassi N, Churilov L, Masters CL, Watson R (2020) Prevalence and clinical associations of tau in Lewy body dementias: a systematic review and meta-analysis. Parkinsonism Relat Disord 80:184\u2013193","journal-title":"Parkinsonism Relat Disord"},{"key":"2345_CR25","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30:7281\u20137289","journal-title":"J Neurosci"},{"key":"2345_CR26","first-page":"216","volume":"76","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Mu\u00f1oz L, Kulisevsky J, Mart\u00ed MJ, Tolosa E, Clarimon J, Lle\u00f3 A, Gelpi E (2017) Regional overlap of pathologies in Lewy body disorders. J Neuropathol Exp Neurol 76:216\u2013224","journal-title":"J Neuropathol Exp Neurol"},{"key":"2345_CR27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-201548","volume":"80","author":"C Cong","year":"2021","unstructured":"Cong C, Zhang W, Qian X, Qiu W, Ma C (2021) Significant overlap of alpha-synuclein, amyloid-beta, and phospho-tau pathologies in neuropathological diagnosis of Lewy-related pathology. J Alzheimers Dis 80:447\u2013458","journal-title":"J Alzheimers Dis"},{"key":"2345_CR28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","volume":"85","author":"D Coughlin","year":"2019","unstructured":"Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Branch Coslett H, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VM, Grossman M, Trojanowski JQ, Irwin DJ (2019) Cognitive and pathological influences of tau pathology in Lewy body disorders. Ann Neurol 85:259\u2013271","journal-title":"Ann Neurol"},{"key":"2345_CR29","doi-asserted-by":"crossref","first-page":"7247325","DOI":"10.1155\/2019\/7247325","volume":"2019","author":"J De Reuck","year":"2019","unstructured":"De Reuck J (2019) The impact of cerebral amyloid angiopathy in various neurodegenerative dementia syndromes: a neuropathological study. Neurol Res Int 2019:7247325","journal-title":"Neurol Res Int"},{"key":"2345_CR30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00002093-200101000-00005","volume":"15","author":"T Del Ser","year":"2001","unstructured":"Del Ser T, Hachinski V, Merskey H, Munoz DG (2001) Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: effect of coexisting Alzheimer-type lesion load. Alzheimer Dis Assoc Disord 15:31\u201344","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2345_CR31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.jnen.0000205145.54457.ea","volume":"65","author":"V Deramecourt","year":"2006","unstructured":"Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65:278\u2013288","journal-title":"J Neuropathol Exp Neurol"},{"key":"2345_CR32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","volume":"20","author":"BN Dugger","year":"2014","unstructured":"Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, Beach TG (2014) Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord 20:525\u2013529","journal-title":"Parkinsonism Relat Disord"},{"key":"2345_CR33","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","volume":"79","author":"P Edison","year":"2008","unstructured":"Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, Villemagne VL, O\u2019Keefe G, N\u00e5gren K, Chaudhury KR, Masters CL, Brooks DJ (2008) Amyloid load in Parkinson\u2019s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79:1331\u20131338","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2345_CR34","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707","journal-title":"Mov Disord"},{"key":"2345_CR35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JPD-181367","volume":"8","author":"SM Fereshtehnejad","year":"2018","unstructured":"Fereshtehnejad SM, L\u00f6kk J, Wimo A, Eriksdotter M (2018) No significant difference in cognitive decline and mortality between Parkinson\u2019s disease dementia and dementia with Lewy bodies: naturalistic longitudinal data from the Swedish Dementia Registry. J Parkinsons Dis 8:553\u2013561","journal-title":"J Parkinsons Dis"},{"key":"2345_CR36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","volume":"14","author":"TJ Ferman","year":"2018","unstructured":"Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford J, Pedraza O, Kantarci K, Boeve BF, Dickson DW (2018) The limbic and neocortical contribution of alpha-synuclein, tau, and amyloid beta to disease duration in dementia with Lewy bodies. Alzheimers Dement 14:330\u2013339","journal-title":"Alzheimers Dement"},{"key":"2345_CR37","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1212\/WNL.0000000000009763","volume":"95","author":"TJ Ferman","year":"2020","unstructured":"Ferman TJ, Aoki N, Boeve BF, Aakre JA, Kantarci K, Graff-Radford J, Parisi JE, Van Gerpen JA, Graff-Radford NR, Uitti RJ, Pedraza O, Murray ME, Wszolek ZK, Reichard RR, Fields JA, Ross OA, Knopman DS, Petersen RC, Dickson DW (2020) Subtypes of dementia with Lewy bodies are associated with \u00ce\u00b1-synuclein and tau distribution. Neurology 95:e155\u2013e165","journal-title":"Neurology"},{"key":"2345_CR38","doi-asserted-by":"crossref","first-page":"e3257","DOI":"10.1212\/WNL.0000000000010943","volume":"95","author":"D Ferreira","year":"2020","unstructured":"Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F, Nedelska Z, Schwarz CG, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR Jr, Petersen RC, Mollenhauer B, Garcia-Ptacek S, Abdelnour C, Hort J, Bonanni L, Oppedal K, Kramberger MG, Boeve BF, Aarsland D, Westman E, Kantarci K (2020) Beta-amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies. Neurology 95:e3257\u2013e3268","journal-title":"Neurology"},{"key":"2345_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gaitpost.2016.08.009","volume":"50","author":"NE Fritz","year":"2016","unstructured":"Fritz NE, Kegelmeyer DA, Kloos AD, Linder S, Park A, Kataki M, Adeli A, Agrawal P, Scharre DW, Kostyk SK (2016) Motor performance differentiates individuals with Lewy body dementia, Parkinson\u2019s and Alzheimer\u2019s disease. Gait Posture 50:1\u20137","journal-title":"Gait Posture"},{"key":"2345_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2010.09.036","volume":"486","author":"H Fujishiro","year":"2010","unstructured":"Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K (2010) Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Neurosci Lett 486:19\u201323","journal-title":"Neurosci Lett"},{"key":"2345_CR41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/NEN.0b013e3181d88e63","volume":"69","author":"E Ghebremedhin","year":"2010","unstructured":"Ghebremedhin E, Rosenberger A, R\u00fcb U, Vuksic M, Berhe T, Bickeb\u00f6ller H, de Vos RA, Thal DR, Deller T (2010) Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases. J Neuropathol Exp Neurol 69:442\u2013448","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 2","key":"2345_CR42","first-page":"S81","volume":"64","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Emre M, Dubois B (2008) Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81-92","journal-title":"Ann Neurol"},{"key":"2345_CR43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","volume":"71","author":"SN Gomperts","year":"2008","unstructured":"Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA (2008) Imaging amyloid deposition in Lewy body diseases. Neurology 71:903\u2013910","journal-title":"Neurology"},{"key":"2345_CR44","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, Johnson K (2016) Tau positron emission tomographic imaging in the Lewy body diseases. JAMA Neurol 73:1334\u20131341","journal-title":"JAMA Neurol"},{"key":"2345_CR45","doi-asserted-by":"crossref","first-page":"117184","DOI":"10.1016\/j.neuroimage.2020.117184","volume":"221","author":"J Gratwicke","year":"2020","unstructured":"Gratwicke J, Oswal A, Akram H, Jahanshahi M, Hariz M, Zrinzo L, Foltynie T, Litvak V (2020) Resting state activity and connectivity of the nucleus basalis of Meynert and globus pallidus in Lewy body dementia and Parkinson\u2019s disease dementia. Neuroimage 221:117184","journal-title":"Neuroimage"},{"key":"2345_CR46","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.parkreldis.2015.07.008","volume":"21","author":"I Gungor","year":"2015","unstructured":"Gungor I, Sarro L, Graff-Radford J, Zuk SM, Tosakulwong N, Przybelski SA, Lesnick T, Boeve BF, Ferman TJ, Smith GE, Knopman DS, Filippi M, Petersen RC, Jack CR Jr, Kantarci K (2015) Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer\u2019s disease. Parkinsonism Relat Disord 21:1101\u20131104","journal-title":"Parkinsonism Relat Disord"},{"key":"2345_CR47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","volume":"154","author":"JL Guo","year":"2013","unstructured":"Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM (2013) Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 154:103\u2013117","journal-title":"Cell"},{"key":"2345_CR48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Song YJ, Harding AJ (2011) Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson\u2019s disease. J Neural Transm (Vienna) 118:713\u2013719","journal-title":"J Neural Transm (Vienna)"},{"key":"2345_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-7091-6846-2_7","volume":"51","author":"LA Hansen","year":"1997","unstructured":"Hansen LA (1997) The Lewy body variant of Alzheimer disease. J Neural Transm Suppl 51:83\u201393","journal-title":"J Neural Transm Suppl"},{"key":"2345_CR50","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/nan.12554","volume":"45","author":"D Hansen","year":"2019","unstructured":"Hansen D, Ling H, Lashley T, Holton JL, Warner TT (2019) Review: Clinical, neuropathological and genetic features of Lewy body dementias. Neuropathol Appl Neurobiol 45:635\u2013654","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2345_CR51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/nan.12648","volume":"47","author":"D Hansen","year":"2021","unstructured":"Hansen D, Ling H, Lashley T, Foley JA, Strand C, Eid TM, Holton JL, Warner TT (2021) Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson\u2019s disease dementia. Neuropathol Appl Neurobiol 47:143\u2013156","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2345_CR52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2017.09.009","volume":"44","author":"MG Heckman","year":"2017","unstructured":"Heckman MG, Kasanuki K, Diehl NN, Koga S, Soto A, Murray ME, Dickson DW, Ross OA (2017) Parkinson\u2019s disease susceptibility variants and severity of Lewy body pathology. Parkinsonism Relat Disord 44:79\u201384","journal-title":"Parkinsonism Relat Disord"},{"key":"2345_CR53","doi-asserted-by":"crossref","first-page":"e1855","DOI":"10.1212\/WNL.0000000000011699","volume":"96","author":"E Howard","year":"2021","unstructured":"Howard E, Irwin DJ, Rascovsky K, Nevler N, Shellikeri S, Tropea TF, Spindler M, Deik A, Chen-Plotkin A, Siderowf A, Dahodwala N, Weintraub D, Shaw LM, Trojanowski JQ, Vaishnavi SN, Wolk DA, Mechanic-Hamilton D, Morley JF, Duda JE, Grossman M, Cousins KA (2021) Cognitive profile and markers of AD-type pathology in patients with Lewy body dementias. Neurology 96:e1855\u2013e1864","journal-title":"Neurology"},{"key":"2345_CR54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2015","unstructured":"Howlett DR, Whitfield D, Johnson M, Attems J, O\u2019Brien JT, Aarsland D, Lai MK, Lee JH, Chen C, Ballard C, Hortob\u00e1gyi T, Francis PT (2015) Regional multiple pathology scores are associated with cognitive decline in Lewy body dementias. Brain Pathol 25:401\u2013408","journal-title":"Brain Pathol"},{"key":"2345_CR55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/mds.27945","volume":"35","author":"M Huber","year":"2020","unstructured":"Huber M, Beyer L, Prix C, Sch\u00f6necker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Van Laere K, Kramberger MG, Trost M, Grmek M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, V\u00f6glein J, Schnabel J, Unterrainer M, Perneczky R, Pogarell O, Buerger K, Catak C, Bartenstein P, Cumming P, Ewers M, Danek A, Levin J, Aarsland D, Nobili F, Rominger A, Brendel M (2020) Metabolic correlates of dopaminergic loss in dementia with Lewy bodies. Mov Disord 35:595\u2013605","journal-title":"Mov Disord"},{"key":"2345_CR56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0404.2004.00292.x","volume":"110","author":"TA Hughes","year":"2004","unstructured":"Hughes TA, Ross HF, Mindham RH, Spokes EG (2004) Mortality in Parkinson\u2019s disease and its association with dementia and depression. Acta Neurol Scand 110:118\u2013123","journal-title":"Acta Neurol Scand"},{"key":"2345_CR57","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4172\/2161-0460.1000444","volume":"8","author":"DJ Irwin","year":"2018","unstructured":"Irwin DJ, Hurtig HI (2018) The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders. J Alzheimers Dis Parkinsonism 8:444","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"2345_CR58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72:587\u2013598","journal-title":"Ann Neurol"},{"key":"2345_CR59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55\u201365","journal-title":"Lancet Neurol"},{"key":"2345_CR60","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1212\/WNL.0000000000005166","volume":"90","author":"DJ Irwin","year":"2018","unstructured":"Irwin DJ, Xie SX, Coughlin D, Nevler N, Akhtar RS, McMillan CT, Lee EB, Wolk DA, Weintraub D, Chen-Plotkin A, Duda JE, Spindler M, Siderowf A, Hurtig HI, Shaw LM, Grossman M, Trojanowski JQ (2018) CSF tau and beta-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders. Neurology 90:e1038\u2013e1046","journal-title":"Neurology"},{"key":"2345_CR61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00401-002-0644-3","volume":"105","author":"E Iseki","year":"2003","unstructured":"Iseki E, Togo T, Suzuki K, Katsuse O, Marui W, de Silva R, Lees A, Yamamoto T, Kosaka K (2003) Dementia with Lewy bodies from the perspective of tauopathy. Acta Neuropathol (Berl) 105:265\u2013270","journal-title":"Acta Neuropathol (Berl)"},{"key":"2345_CR62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.parkreldis.2005.09.001","volume":"12","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA (2006) Pathological substrate of dementia in Parkinson\u2019s disease\u2014its relation to DLB and DLBD. Parkinsonism Relat Disord 12:119\u2013120","journal-title":"Parkinsonism Relat Disord"},{"key":"2345_CR63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000304033.82293.9a","volume":"70","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) Re: In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology 70:407\u2013408","journal-title":"Neurology"},{"key":"2345_CR64","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000197890","volume":"24","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009) Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Front Neurol Neurosci 24:114\u2013125","journal-title":"Front Neurol Neurosci"},{"key":"2345_CR65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000285518","volume":"7","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010a) Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases. Neurodegener Dis 7:112\u2013115","journal-title":"Neurodegener Dis"},{"key":"2345_CR66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-009-0613-1","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010b) The neuropathologic substrate of Parkinson disease dementia. Acta Neuropathol 119:151\u2013153","journal-title":"Acta Neuropathol"},{"key":"2345_CR67","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1100\/2011\/371893","volume":"11","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA (2011) Interaction between alpha-synuclein and other proteins in neurodegenerative disorders. Sci World J 11:1893\u20131907","journal-title":"Sci World J"},{"key":"2345_CR68","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1582-4934.2011.01507.x","volume":"16","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Interaction between pathogenic proteins in neurodegenerative disorders. J Cell Mol Med 16:1166\u20131183","journal-title":"J Cell Mol Med"},{"key":"2345_CR69","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","volume":"125","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018) Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies. J Neural Transm (Vienna) 125:615\u2013650","journal-title":"J Neural Transm (Vienna)"},{"key":"2345_CR70","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1212\/WNL.0000000000009167","volume":"94","author":"KA Jellinger","year":"2020","unstructured":"Jellinger KA (2020) Striatal dopamine transporter activity may predict \u00df-amyloid pathology in dementia with Lewy bodies. Neurology 94:557\u2013558","journal-title":"Neurology"},{"key":"2345_CR71","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12708","author":"KA Jellinger","year":"2021","unstructured":"Jellinger KA (2021) Morphological differences between dementia with Lewy bodies and Parkinson's disease-dementia. Letter to the Editor. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12708","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2345_CR72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","volume":"112","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA, Attems J (2006a) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol (Berl) 112:253\u2013260","journal-title":"Acta Neuropathol (Berl)"},{"key":"2345_CR73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0404.2006.00665.x","volume":"114","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA, Attems J (2006b) Prevalence and impact of cerebrovascular pathology in Alzheimer\u2019s disease and parkinsonism. Acta Neurol Scand 114:38\u201346","journal-title":"Acta Neurol Scand"},{"key":"2345_CR74","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00702-007-0856-8","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA, Attems J (2008a) Cerebral amyloid angiopathy in Lewy body disease. J Neural Transm (Vienna) 115:473\u2013482","journal-title":"J Neural Transm (Vienna)"},{"key":"2345_CR75","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA, Attems J (2008b) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:427\u2013436","journal-title":"Acta Neuropathol"},{"key":"2345_CR76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med 16:34","journal-title":"BMC Med"},{"key":"2345_CR77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s007020200027","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson\u2019s disease. J Neural Transm 109:329\u2013339","journal-title":"J Neural Transm"},{"key":"2345_CR78","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1468-1331.2007.01880.x","volume":"14","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA, Lauda F, Attems J (2007a) Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. Eur J Neurol 14:923\u2013928","journal-title":"Eur J Neurol"},{"key":"2345_CR79","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000107703","volume":"4","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA, Wenning GK, Seppi K (2007b) Predictors of survival in dementia with lewy bodies and Parkinson dementia. Neurodegener Dis 4:428\u2013430","journal-title":"Neurodegener Dis"},{"key":"2345_CR80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2017.12.018","volume":"385","author":"H Joki","year":"2018","unstructured":"Joki H, Higashiyama Y, Nakae Y, Kugimoto C, Doi H, Kimura K, Kishida H, Ueda N, Nakano T, Takahashi T, Koyano S, Takeuchi H, Tanaka F (2018) White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson\u2019s disease with dementia, and Alzheimer\u2019s disease. J Neurol Sci 385:99\u2013104","journal-title":"J Neurol Sci"},{"key":"2345_CR81","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.parkreldis.2010.08.021","volume":"16","author":"P Jokinen","year":"2010","unstructured":"Jokinen P, Scheinin N, Aalto S, N\u00e5gren K, Savisto N, Parkkola R, Rokka J, Haaparanta M, R\u00f6ytt\u00e4 M, Rinne JO (2010) [(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson\u2019s disease with and without dementia. Parkinsonism Relat Disord 16:666\u2013670","journal-title":"Parkinsonism Relat Disord"},{"key":"2345_CR82","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00401-009-0597-x","volume":"118","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Pearce RK (2009) The morbid anatomy of dementia in Parkinson\u2019s disease. Acta Neuropathol 118:587\u2013598","journal-title":"Acta Neuropathol"},{"key":"2345_CR83","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nbd.2010.10.005","volume":"41","author":"ME Kalaitzakis","year":"2011","unstructured":"Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM (2011) Striatal A\u00df peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes. Neurobiol Dis 41:377\u2013384","journal-title":"Neurobiol Dis"},{"key":"2345_CR84","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2017","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR Jr, Petersen RC (2017) AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol 81:58\u201367","journal-title":"Ann Neurol"},{"key":"2345_CR85","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/STROKEAHA.120.031073","volume":"52","author":"A Kapasi","year":"2021","unstructured":"Kapasi A, Leurgans SE, Arvanitakis Z, Barnes LL, Bennett DA, Schneider JA (2021) Abeta (amyloid beta) and tau tangle pathology modifies the association between small vessel disease and cortical microinfarcts. Stroke 52:1012\u20131021","journal-title":"Stroke"},{"key":"2345_CR86","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3174\/ajnr.A4337","volume":"36","author":"SW Kim","year":"2015","unstructured":"Kim SW, Chung SJ, Oh YS, Yoon JH, Sunwoo MK, Hong JY, Kim JS, Lee PH (2015) Cerebral microbleeds in patients with dementia with Lewy bodies and Parkinson disease dementia. AJNR Am J Neuroradiol 36:1642\u20131647","journal-title":"AJNR Am J Neuroradiol"},{"key":"2345_CR87","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mds.27252","volume":"33","author":"SH Lee","year":"2018","unstructured":"Lee SH, Cho H, Choi JY, Lee JH, Ryu YH, Lee MS, Lyoo CH (2018) Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases. Mov Disord 33:262\u2013272","journal-title":"Mov Disord"},{"key":"2345_CR88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","volume":"88","author":"AW Lemstra","year":"2017","unstructured":"Lemstra AW, de Beer MH, Teunissen CE, Schreuder C, Scheltens P, van der Flier WM, Sikkes SA (2017) Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 88:113\u2013118","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2345_CR89","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","volume":"50","author":"SM Lim","year":"2009","unstructured":"Lim SM, Katsifis A, Villemagne VL, Best R, Jones G, Saling M, Bradshaw J, Merory J, Woodward M, Hopwood M, Rowe CC (2009) The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med 50:1638\u20131645","journal-title":"J Nucl Med"},{"key":"2345_CR90","first-page":"19","volume":"3","author":"S Love","year":"2014","unstructured":"Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG (2014) Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 3:19\u201332","journal-title":"Am J Neurodegener Dis"},{"key":"2345_CR91","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroimage.2007.09.072","volume":"39","author":"W Maetzler","year":"2008","unstructured":"Maetzler W, Reimold M, Liepelt I, Solbach C, Leyhe T, Schweitzer K, Eschweiler GW, Mittelbronn M, Gaenslen A, Uebele M, Reischl G, Gasser T, Machulla HJ, Bares R, Berg D (2008) [11C]PIB binding in Parkinson\u2019s disease dementia. Neuroimage 39:1027\u20131033","journal-title":"Neuroimage"},{"key":"2345_CR92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JAD-191151","volume":"74","author":"M Malek-Ahmadi","year":"2020","unstructured":"Malek-Ahmadi M, Perez SE, Chen K, Mufson EJ (2020) Braak stage, cerebral amyloid angiopathy, and cognitive decline in early Alzheimer\u2019s disease. J Alzheimers Dis 74:189\u2013197","journal-title":"J Alzheimers Dis"},{"key":"2345_CR93","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","volume":"31","author":"PK Mandal","year":"2006","unstructured":"Mandal PK, Pettegrew JW, Masliah E, Hamilton RL, Mandal R (2006) Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer\u2019s and Parkinson\u2019s in dementia with Lewy body disease. Neurochem Res 31:1153\u20131162","journal-title":"Neurochem Res"},{"key":"2345_CR94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00702-019-02129-2","volume":"127","author":"A Martini","year":"2020","unstructured":"Martini A, Weis L, Schifano R, Pistonesi F, Fiorenzato E, Antonini A, Biundo R (2020) Differences in cognitive profiles between Lewy body and Parkinson\u2019s disease dementia. J Neural Transm (Vienna) 127:323\u2013330","journal-title":"J Neural Transm (Vienna)"},{"key":"2345_CR95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/brain\/awz311","volume":"143","author":"E Matar","year":"2020","unstructured":"Matar E, Shine JM, Halliday GM, Lewis SJG (2020) Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework. Brain 143:31\u201346","journal-title":"Brain"},{"key":"2345_CR96","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"2345_CR97","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"2345_CR98","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/01.WNL.0000149510.41793.50","volume":"64","author":"A Nagano-Saito","year":"2005","unstructured":"Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, Dagher A, Ito K (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64:224\u2013229","journal-title":"Neurology"},{"key":"2345_CR99","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska Z, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Murray ME, Gunter JL, Senjem ML, Vemuri P, Smith GE, Geda YE, Graff-Radford J, Knopman DS, Petersen RC, Parisi JE, Dickson DW, Jack CR Jr, Kantarci K (2015) Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging 36:452\u2013461","journal-title":"Neurobiol Aging"},{"key":"2345_CR100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jnen\/nlaa160","volume":"80","author":"JB Nichols","year":"2021","unstructured":"Nichols JB, Malek-Ahmadi M, Tariot PN, Serrano GE, Sue LI, Beach TG (2021) Vascular lesions, APOE epsilon4, and tau pathology in Alzheimer disease. J Neuropathol Exp Neurol 80:240\u2013246","journal-title":"J Neuropathol Exp Neurol"},{"key":"2345_CR101","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.expneurol.2007.11.019","volume":"210","author":"K Obi","year":"2008","unstructured":"Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T, Mizuno Y, Mochizuki H (2008) Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Exp Neurol 210:409\u2013420","journal-title":"Exp Neurol"},{"key":"2345_CR102","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324606","author":"FPM Oliveira","year":"2021","unstructured":"Oliveira FPM, Walker Z, Walker RWH, Attems J, Castanheira JC, Silva \u00c3, Oliveira C, Vaz S, Silva M, Costa DC (2021) (123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson\u2019s disease and Alzheimer\u2019s disease: a new quantitative analysis of autopsy confirmed cases. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2020-324606","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2345_CR103","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/brain\/awaa411","volume":"144","author":"A Oswal","year":"2021","unstructured":"Oswal A, Gratwicke J, Akram H, Jahanshahi M, Zaborszky L, Brown P, Hariz M, Zrinzo L, Foltynie T, Litvak V (2021) Cortical connectivity of the nucleus basalis of Meynert in Parkinson\u2019s disease and Lewy body dementias. Brain 144:781\u2013788","journal-title":"Brain"},{"key":"2345_CR104","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5","journal-title":"Mol Neurodegener"},{"key":"2345_CR105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000375363","volume":"5","author":"M Petrova","year":"2015","unstructured":"Petrova M, Mehrabian-Spasova S, Aarsland D, Raycheva M, Traykov L (2015) Clinical and neuropsychological differences between mild Parkinson\u2019s disease dementia and dementia with Lewy bodies. Dement Geriatr Cogn Dis Extra 5:212\u2013220","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"2345_CR106","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","volume":"26","author":"O Pletnikova","year":"2005","unstructured":"Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, Marsh L, Troncoso JC (2005) Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 26:1183\u20131192","journal-title":"Neurobiol Aging"},{"key":"2345_CR107","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-009-0501-8","volume":"118","author":"T Revesz","year":"2009","unstructured":"Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J (2009) Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118:115\u2013130","journal-title":"Acta Neuropathol"},{"key":"2345_CR108","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamaneurol.2014.681","volume":"71","author":"JM Ringman","year":"2014","unstructured":"Ringman JM, Sachs MC, Zhou Y, Monsell SE, Saver JL, Vinters HV (2014) Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease. JAMA Neurol 71:878\u2013883","journal-title":"JAMA Neurol"},{"key":"2345_CR109","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3233\/JAD-201187","volume":"80","author":"SG Ryman","year":"2021","unstructured":"Ryman SG, Yutsis M, Tian L, Henderson VW, Montine TJ, Salmon DP, Galasko D, Poston KL (2021) Cognition at each stage of Lewy body disease with co-occurring Alzheimer\u2019s disease pathology. J Alzheimers Dis 80:1243\u20131256","journal-title":"J Alzheimers Dis"},{"key":"2345_CR110","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y Saito","year":"2003","unstructured":"Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644\u2013654","journal-title":"J Neuropathol Exp Neurol"},{"key":"2345_CR111","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00702-011-0651-4","volume":"118","author":"M Salkovic-Petrisic","year":"2011","unstructured":"Salkovic-Petrisic M, Osmanovic-Barilar J, Br\u00fcckner MK, Hoyer S, Arendt T, Riederer P (2011) Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer\u2019s disease: a long-term follow up study. J Neural Transm (Vienna) 118:765\u2013772","journal-title":"J Neural Transm (Vienna)"},{"key":"2345_CR112","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","volume":"73","author":"H Shimada","year":"2009","unstructured":"Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N, Ota T, Asahina M, Fukushi K, Kuwabara S, Hattori T, Suhara T, Irie T (2009) Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73:273\u2013278","journal-title":"Neurology"},{"key":"2345_CR113","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1212\/WNL.0000000000007855","volume":"93","author":"J Shirvan","year":"2019","unstructured":"Shirvan J, Clement N, Ye R, Katz S, Schultz A, Johnson KA, Gomez-Isla T, Frosch M, Growdon JH, Gomperts SN (2019) Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease. Neurology 93:e476\u2013e484","journal-title":"Neurology"},{"key":"2345_CR114","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/nan.12308","volume":"42","author":"M Sierra","year":"2016","unstructured":"Sierra M, Gelpi E, Mart\u00ed MJ, Compta Y (2016) Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum. Neuropathol Appl Neurobiol 42:451\u2013462","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2345_CR115","doi-asserted-by":"crossref","first-page":"e2076","DOI":"10.1212\/WNL.0000000000009434","volume":"94","author":"DS Smirnov","year":"2020","unstructured":"Smirnov DS, Galasko D, Edland SD, Filoteo JV, Hansen LA, Salmon DP (2020) Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies. Neurology 94:e2076\u2013e2087","journal-title":"Neurology"},{"key":"2345_CR116","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1474-4422(11)70307-6","volume":"11","author":"EE Smith","year":"2012","unstructured":"Smith EE, Schneider JA, Wardlaw JM, Greenberg SM (2012) Cerebral microinfarcts: the invisible lesions. Lancet Neurol 11:272\u2013282","journal-title":"Lancet Neurol"},{"key":"2345_CR117","first-page":"1234","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG (2019) Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 90:1234\u20131243","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2345_CR118","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134:187\u2013205","journal-title":"Acta Neuropathol"},{"key":"2345_CR119","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/acn3.51183","volume":"7","author":"N Spotorno","year":"2020","unstructured":"Spotorno N, Coughlin DG, Olm CA, Wolk D, Vaishnavi SN, Shaw LM, Dahodwala N, Morley JF, Duda JE, Deik AF, Spindler MA, Chen-Plotkin A, Lee EB, Trojanowski JQ, McMillan CT, Weintraub D, Grossman M, Irwin DJ (2020) Tau pathology associates with in vivo cortical thinning in Lewy body disorders. Ann Clin Transl Neurol 7:2342\u20132355","journal-title":"Ann Clin Transl Neurol"},{"key":"2345_CR120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13195-014-0077-y","volume":"6","author":"M Swirski","year":"2014","unstructured":"Swirski M, Miners JS, de Silva R, Lashley T, Ling H, Holton J, Revesz T, Love S (2014) Evaluating the relationship between amyloid-beta and alpha-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson\u2019s disease. Alzheimers Res Ther 6:77","journal-title":"Alzheimers Res Ther"},{"key":"2345_CR121","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, Braak E, Braak H (2000) Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733\u2013748","journal-title":"J Neuropathol Exp Neurol"},{"key":"2345_CR122","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000082349","volume":"19","author":"A Thomas","year":"2005","unstructured":"Thomas A, Ballard C, Kenny RA, O\u2019Brien J, Oakley A, Kalaria R (2005) Correlation of entorhinal amyloid with memory in Alzheimer\u2019s and vascular but not Lewy body dementia. Dement Geriatr Cogn Disord 19:57\u201360","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2345_CR123","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ (2016) Pathological alpha-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol 131:393\u2013409","journal-title":"Acta Neuropathol"},{"key":"2345_CR124","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1038\/s41598-021-86617-0","volume":"11","author":"HH Tsai","year":"2021","unstructured":"Tsai HH, Tsai LK, Lo YL, Lin CH (2021) Amyloid related cerebral microbleed and plasma Abeta40 are associated with cognitive decline in Parkinson\u2019s disease. Sci Rep 11:7115","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"2345_CR125","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.parkreldis.2004.10.014","volume":"11","author":"Y Tsuboi","year":"2005","unstructured":"Tsuboi Y, Dickson DW (2005) Dementia with Lewy bodies and Parkinson\u2019s disease with dementia: are they different? Parkinsonism Relat Disord 11(Suppl 1):S47-51","journal-title":"Parkinsonism Relat Disord"},{"key":"2345_CR126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neurobiolaging.2018.07.005","volume":"71","author":"JJ van der Zande","year":"2018","unstructured":"van der Zande JJ, Steenwijk MD, Ten Kate M, Wattjes MP, Scheltens P, Lemstra AW (2018) Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer\u2019s disease pathology. Neurobiol Aging 71:171\u2013178","journal-title":"Neurobiol Aging"},{"key":"2345_CR127","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D (2015) Lewy body dementias. Lancet 386:1683\u20131697","journal-title":"Lancet"},{"key":"2345_CR128","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jnc.14698","volume":"150","author":"L Walker","year":"2019","unstructured":"Walker L, Stefanis L, Attems J (2019) Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies\u2014current issues and future directions. J Neurochem 150:467\u2013474","journal-title":"J Neurochem"},{"key":"2345_CR129","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.12688\/f1000research.11725.1","volume":"6","author":"RS Weil","year":"2017","unstructured":"Weil RS, Lashley TL, Bras J, Schrag AE, Schott JM (2017) Current concepts and controversies in the pathogenesis of Parkinson\u2019s disease dementia and Dementia with Lewy Bodies. F1000Res 6:1604","journal-title":"F1000Res"},{"key":"2345_CR130","doi-asserted-by":"crossref","first-page":"102504","DOI":"10.1016\/j.nicl.2020.102504","volume":"28","author":"EE Wolters","year":"2020","unstructured":"Wolters EE, van de Beek M, Ossenkoppele R, Golla SSV, Verfaillie SCJ, Coomans EM, Timmers T, Visser D, Tuncel H, Barkhof F, Boellaard R, Windhorst AD, van der Flier WM, Scheltens P, Lemstra AW, van Berckel BNM (2020) Tau PET and relative cerebral blood flow in dementia with Lewy bodies: a PET study. Neuroimage Clin 28:102504","journal-title":"Neuroimage Clin"},{"key":"2345_CR131","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1212\/WNL.42.11.2131","volume":"42","author":"E Wu","year":"1992","unstructured":"Wu E, Lipton RB, Dickson DW (1992) Amyloid angiopathy in diffuse Lewy body disease. Neurology 42:2131\u20132135","journal-title":"Neurology"},{"key":"2345_CR132","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.25707","volume":"87","author":"HS Yoo","year":"2020","unstructured":"Yoo HS, Lee S, Chung SJ, Lee YH, Lee PH, Sohn YH, Yun M, Ye BS (2020a) Dopaminergic depletion, beta-amyloid burden, and cognition in Lewy body disease. Ann Neurol 87:739\u2013750","journal-title":"Ann Neurol"},{"key":"2345_CR133","doi-asserted-by":"crossref","first-page":"e1344","DOI":"10.1212\/WNL.0000000000009168","volume":"94","author":"HS Yoo","year":"2020","unstructured":"Yoo HS, Lee S, Chung SJ, Lee YH, Ye BS, Sohn YH, Yun M, Lee PH (2020b) Clinical and striatal dopamine transporter predictors of beta-amyloid in dementia with Lewy bodies. Neurology 94:e1344\u2013e1352","journal-title":"Neurology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02345-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-021-02345-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02345-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:27:20Z","timestamp":1698971240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-021-02345-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1007\/s00702-021-02345-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"type":"print","value":"0300-9564"},{"type":"electronic","value":"1435-1463"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"15 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}